Nexeon Medsystems Inc
OTC:NXNN
Operating Margin
Nexeon Medsystems Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
N
|
Nexeon Medsystems Inc
OTC:NXNN
|
196.6 USD |
-58%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
230.3B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
182.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
149.8B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
143.5B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.7B USD |
20%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
51.8B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.3B USD |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
43.5B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.3B USD |
29%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
275.5B CNY |
34%
|
Nexeon Medsystems Inc
Glance View
Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2017-08-01. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology. In addition, the Company is developing and commercializing NNS, an implantable neurostimulation and recording platform. The Company’s wholly-owned subsidiaries include Nexeon Medsystems Europe, SARL (Nexeon Europe), Nexeon Medsystems Puerto Rico Operating Company Corporation (NXPROC) and Pulsus Medical LLC.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Nexeon Medsystems Inc's most recent financial statements, the company has Operating Margin of -57.7%.
You don't have any saved screeners yet